Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
941
Total Claims
$1.0M
Drug Cost
135
Beneficiaries
$7,704
Cost/Patient
Risk Score Breakdown 3/100
Score components are additive. Read full methodology
Peer Comparison vs. 5,387 Infectious Disease providers
-4%
Cost per patient vs peers
$7,704 vs $8,010 avg
+35%
Brand preference vs peers
28.7% vs 21.3% avg
Brand vs Generic
Brand: 270 claims · $935K
Generic: 671 claims · $105K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Bictegrav/Emtricit/Tenofov Ala | 119 | $532K |
| Elviteg/Cob/Emtri/Tenof Alafen | 19 | $113K |
| Posaconazole | 11 | $58K |
| Darunavir/Cob/Emtri/Tenof Alaf | 11 | $49K |
| Dolutegravir/Rilpivirine | 11 | $39K |
| Dolutegravir Sodium | 13 | $27K |
| Emtricitabine/Tenofov Alafenam | 12 | $25K |
| Vancomycin Hcl | 39 | $7,098 |
| Daptomycin | 17 | $6,690 |
| Vibegron | 12 | $6,276 |
| Cefepime Hcl | 25 | $6,142 |
| Rifampin | 44 | $2,917 |
| Ethambutol Hcl | 37 | $2,001 |
| Doxycycline Monohydrate | 40 | $1,803 |
| Cefpodoxime Proxetil | 16 | $1,744 |
Prescribing Profile
29
Unique Drugs
3.0
Anomaly Score
Patient Profile
71
Avg Age
48%
Female
2.12
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About